Search
for
Sort by
Research 721–750 of 1000+
- Severe cutaneous adverse reactions to drugs
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Transforming growth factor-β in stem cells and tissue homeostasis
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- COVID-19 and Sex Differences
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- ATP-dependent chromatin remodeling during mammalian development
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Alopecia areata
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Probiotic Bacteria Induce a ‘Glow of Health’
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Drug-Induced Skin, Nail and Hair Disorders
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Regulatory T cells in skin
- Neurogenic Inflammation in Stress-Induced Termination of Murine Hair Growth Is Promoted by Nerve Growth Factor
- The human hair: from anatomy to physiology
- Skin biopsy
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- Delivery and targeting of nanoparticles into hair follicles
- Trichoscopy of alopecia areata: An update
- THE PATHOGENESIS OF ALOPECIA AREATA
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Epidermal Notch1 recruits RORγ+ group 3 innate lymphoid cells to orchestrate normal skin repair
- Alopecia Areata Update
- Ritlecitinib: First Approval